Atlas Trials

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Clinical trial NCT00268450 · TERMINATED

Trial details

NCT number
NCT00268450
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2005-09-21
Primary completion
2012-04-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.